C07D 501/62
Compounds further condensed with a carbocyclic ring or ring system
C07D501/62 (Compounds further condensed with a carbocyclic ring or ring system) appears on 2 US grants and 3 published applications in this corpus.
Search patents in C07D- Granted patents
- 2
- Published applications
- 3
- Assignees
- 2
- Inventors
- 7
- Latest grant
- 9 Jul 2019
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 1 | 0 |
| 2018 | 0 | 1 |
| 2019 | 1 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
By publication year.
Recent patents
- 2,7-disubstituted cephalosporin derivatives as β-lactamase substrates and methods for their use for the diagnosis of tuberculosis9 Jul 2019US 10,344,165 B2The Board of Trustees of the Leland Stanford Junior University
- 2,7-disubstituted cephalosporin derivatives as beta-lactamase substrates and methods for their use for the diagnosis of tuberculosis5 Dec 2017US 9,834,681 B2The Board of Trustees of the Leland Stanford Junior University
- Bioluminogenic assay for drug-resistance bacteria detection11 Jul 2024US 2024/0229098 A1The Board of Trustees of the Leland Stanford Junior University
- 2,7-disubstituted cephalosporin derivatives as beta-lactamase substrates and methods for their use for the diagnosis of tuberculosis5 Apr 2018US 2018/0094139 A1The Board of Trustees of the Leland Stanford Junior University
- 2,7-disubstituted cephalosporin derivatives as beta-lactamase substrates and methods for their use for the diagnosis of tuberculosis6 Aug 2015US 2015/0219653 A1The Board of Trustees of the Leland Stanford Junior University
Most cited
By later US patents